Restricting age for RV administration limits immunization rates, with delayed DTaP initiation linked to higher non-initiation.

Pediatric MRSA hospitalizations declined between 2016 and 2024, but ICU admission rates remained stable alongside shifts in drug selection.

FDA expands Tivicay PD (dolutegravir) approval for HIV-1 treatment to neonates from birth up to 4 weeks of age weighing at least 2kg.

Writing style can explain about half of observed disparities in care team response to messages sent by patients.

Preinfection COVID-19 vaccination lowers the risk for persistent post-COVID-19 conditions in children and adolescents.

Prolonged bacteremia in pediatric AHOAI increases early complications but does not dictate long-term orthopedic outcomes.

Older adults hospitalized for COVID-19 during the Omicron era face a higher risk for MACE and mortality than those hospitalized for influenza.

Normalizing BMI is associated with a reduced risk for progression to stage 3 type 1 diabetes, with the association mainly observed in youth.